Use Of Complement Pathway Inhibitors To Treat Ocular Diseases
Patent No. EP2500030 (titled "Use Of Complement Pathway Inhibitors To Treat Ocular Diseases") was filed by Genentech on Nov 4, 2006. The application was issued on Aug 8, 2018.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents
EP2500030
- Application Number
- EP12172001A
- Filing Date
- Nov 4, 2006
- Status
- Patent Maintained As Amended
- Jul 6, 2018
- Publication Date
- Aug 8, 2018
- External Links
- Slate, Register , Google Patents